Pharma & Healthcare
Global Opioid Induced Side Effects Treatment Market Insights, Forecast to 2030
- Mar 11, 25
- ID: 4143
- Pages: 91
- Figures: 115
- Views: 15
Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid receptors on nerve cells in body and are well known for the management of acute pain and cancer related pain among patients of all age group.
Market Analysis and Insights: Global Opioid Induced Side Effects Treatment Market
The global Opioid Induced Side Effects Treatment market is projected to grow from US$ 1409 million in 2024 to US$ 1916.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Opioid Induced Side Effects Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Opioid Induced Side Effects Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Opioid Induced Side Effects Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Induced Side Effects Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Opioid Induced Side Effects Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Opioid Induced Side Effects Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals
Segment by Type
Risperidone
Methylphenidate
Cetirizine
Other
Segment by Application
Drug Overdose Treatment
Pain Treatment
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Opioid Induced Side Effects Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Side Effects Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Induced Side Effects Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Market Analysis and Insights: Global Opioid Induced Side Effects Treatment Market
The global Opioid Induced Side Effects Treatment market is projected to grow from US$ 1409 million in 2024 to US$ 1916.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.3% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Opioid Induced Side Effects Treatment market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Opioid Induced Side Effects Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Opioid Induced Side Effects Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Induced Side Effects Treatment revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Opioid Induced Side Effects Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Opioid Induced Side Effects Treatment revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Shionogi
Cubist Pharmaceuticals
SLA Pharma
AstraZeneca
AIKO Biotechnology
Progenics Pharmaceuticals
Segment by Type
Risperidone
Methylphenidate
Cetirizine
Other
Segment by Application
Drug Overdose Treatment
Pain Treatment
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Opioid Induced Side Effects Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Opioid Induced Side Effects Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Induced Side Effects Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Risperidone
1.2.3 Methylphenidate
1.2.4 Cetirizine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Overdose Treatment
1.3.3 Pain Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Side Effects Treatment Market Perspective (2019-2030)
2.2 Global Opioid Induced Side Effects Treatment Growth Trends by Region
2.2.1 Opioid Induced Side Effects Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opioid Induced Side Effects Treatment Historic Market Size by Region (2019-2024)
2.2.3 Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2025-2030)
2.3 Opioid Induced Side Effects Treatment Market Dynamics
2.3.1 Opioid Induced Side Effects Treatment Industry Trends
2.3.2 Opioid Induced Side Effects Treatment Market Drivers
2.3.3 Opioid Induced Side Effects Treatment Market Challenges
2.3.4 Opioid Induced Side Effects Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Opioid Induced Side Effects Treatment by Players
3.1.1 Global Opioid Induced Side Effects Treatment Revenue by Players (2019-2024)
3.1.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Opioid Induced Side Effects Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Opioid Induced Side Effects Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Side Effects Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Side Effects Treatment Revenue in 2023
3.5 Global Key Players of Opioid Induced Side Effects Treatment Head office and Area Served
3.6 Global Key Players of Opioid Induced Side Effects Treatment, Product and Application
3.7 Global Key Players of Opioid Induced Side Effects Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Side Effects Treatment Breakdown Data by Type
4.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Type (2019-2024)
4.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2025-2030)
5 Opioid Induced Side Effects Treatment Breakdown Data by Application
5.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Application (2019-2024)
5.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opioid Induced Side Effects Treatment Market Size (2019-2030)
6.2 North America Opioid Induced Side Effects Treatment Market Size by Type
6.2.1 North America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
6.2.2 North America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
6.2.3 North America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
6.3 North America Opioid Induced Side Effects Treatment Market Size by Application
6.3.1 North America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
6.3.2 North America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
6.3.3 North America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
6.4 North America Opioid Induced Side Effects Treatment Market Size by Country
6.4.1 North America Opioid Induced Side Effects Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
6.4.3 North America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Opioid Induced Side Effects Treatment Market Size (2019-2030)
7.2 Europe Opioid Induced Side Effects Treatment Market Size by Type
7.2.1 Europe Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
7.2.2 Europe Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
7.2.3 Europe Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
7.3 Europe Opioid Induced Side Effects Treatment Market Size by Application
7.3.1 Europe Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
7.3.2 Europe Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
7.3.3 Europe Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
7.4 Europe Opioid Induced Side Effects Treatment Market Size by Country
7.4.1 Europe Opioid Induced Side Effects Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
7.4.3 Europe Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Opioid Induced Side Effects Treatment Market Size (2019-2030)
8.2 China Opioid Induced Side Effects Treatment Market Size by Type
8.2.1 China Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
8.2.2 China Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
8.2.3 China Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
8.3 China Opioid Induced Side Effects Treatment Market Size by Application
8.3.1 China Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
8.3.2 China Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
8.3.3 China Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Opioid Induced Side Effects Treatment Market Size (2019-2030)
9.2 Asia Opioid Induced Side Effects Treatment Market Size by Type
9.2.1 Asia Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
9.2.2 Asia Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
9.2.3 Asia Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
9.3 Asia Opioid Induced Side Effects Treatment Market Size by Application
9.3.1 Asia Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
9.3.2 Asia Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
9.3.3 Asia Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
9.4 Asia Opioid Induced Side Effects Treatment Market Size by Region
9.4.1 Asia Opioid Induced Side Effects Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Opioid Induced Side Effects Treatment Market Size by Region (2019-2024)
9.4.3 Asia Opioid Induced Side Effects Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Shionogi
11.1.1 Shionogi Company Details
11.1.2 Shionogi Business Overview
11.1.3 Shionogi Opioid Induced Side Effects Treatment Introduction
11.1.4 Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.1.5 Shionogi Recent Developments
11.2 Cubist Pharmaceuticals
11.2.1 Cubist Pharmaceuticals Company Details
11.2.2 Cubist Pharmaceuticals Business Overview
11.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.2.4 Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.2.5 Cubist Pharmaceuticals Recent Developments
11.3 SLA Pharma
11.3.1 SLA Pharma Company Details
11.3.2 SLA Pharma Business Overview
11.3.3 SLA Pharma Opioid Induced Side Effects Treatment Introduction
11.3.4 SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.3.5 SLA Pharma Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Opioid Induced Side Effects Treatment Introduction
11.4.4 AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.4.5 AstraZeneca Recent Developments
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Details
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.5.5 AIKO Biotechnology Recent Developments
11.6 Progenics Pharmaceuticals
11.6.1 Progenics Pharmaceuticals Company Details
11.6.2 Progenics Pharmaceuticals Business Overview
11.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.6.4 Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.6.5 Progenics Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Risperidone
1.2.3 Methylphenidate
1.2.4 Cetirizine
1.2.5 Other
1.3 Market by Application
1.3.1 Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Overdose Treatment
1.3.3 Pain Treatment
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Opioid Induced Side Effects Treatment Market Perspective (2019-2030)
2.2 Global Opioid Induced Side Effects Treatment Growth Trends by Region
2.2.1 Opioid Induced Side Effects Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Opioid Induced Side Effects Treatment Historic Market Size by Region (2019-2024)
2.2.3 Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2025-2030)
2.3 Opioid Induced Side Effects Treatment Market Dynamics
2.3.1 Opioid Induced Side Effects Treatment Industry Trends
2.3.2 Opioid Induced Side Effects Treatment Market Drivers
2.3.3 Opioid Induced Side Effects Treatment Market Challenges
2.3.4 Opioid Induced Side Effects Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Opioid Induced Side Effects Treatment by Players
3.1.1 Global Opioid Induced Side Effects Treatment Revenue by Players (2019-2024)
3.1.2 Global Opioid Induced Side Effects Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Opioid Induced Side Effects Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Opioid Induced Side Effects Treatment, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Opioid Induced Side Effects Treatment Market Concentration Ratio
3.4.1 Global Opioid Induced Side Effects Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid Induced Side Effects Treatment Revenue in 2023
3.5 Global Key Players of Opioid Induced Side Effects Treatment Head office and Area Served
3.6 Global Key Players of Opioid Induced Side Effects Treatment, Product and Application
3.7 Global Key Players of Opioid Induced Side Effects Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Opioid Induced Side Effects Treatment Breakdown Data by Type
4.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Type (2019-2024)
4.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2025-2030)
5 Opioid Induced Side Effects Treatment Breakdown Data by Application
5.1 Global Opioid Induced Side Effects Treatment Historic Market Size by Application (2019-2024)
5.2 Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Opioid Induced Side Effects Treatment Market Size (2019-2030)
6.2 North America Opioid Induced Side Effects Treatment Market Size by Type
6.2.1 North America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
6.2.2 North America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
6.2.3 North America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
6.3 North America Opioid Induced Side Effects Treatment Market Size by Application
6.3.1 North America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
6.3.2 North America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
6.3.3 North America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
6.4 North America Opioid Induced Side Effects Treatment Market Size by Country
6.4.1 North America Opioid Induced Side Effects Treatment Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
6.4.3 North America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Opioid Induced Side Effects Treatment Market Size (2019-2030)
7.2 Europe Opioid Induced Side Effects Treatment Market Size by Type
7.2.1 Europe Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
7.2.2 Europe Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
7.2.3 Europe Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
7.3 Europe Opioid Induced Side Effects Treatment Market Size by Application
7.3.1 Europe Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
7.3.2 Europe Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
7.3.3 Europe Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
7.4 Europe Opioid Induced Side Effects Treatment Market Size by Country
7.4.1 Europe Opioid Induced Side Effects Treatment Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
7.4.3 Europe Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Opioid Induced Side Effects Treatment Market Size (2019-2030)
8.2 China Opioid Induced Side Effects Treatment Market Size by Type
8.2.1 China Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
8.2.2 China Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
8.2.3 China Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
8.3 China Opioid Induced Side Effects Treatment Market Size by Application
8.3.1 China Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
8.3.2 China Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
8.3.3 China Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Opioid Induced Side Effects Treatment Market Size (2019-2030)
9.2 Asia Opioid Induced Side Effects Treatment Market Size by Type
9.2.1 Asia Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
9.2.2 Asia Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
9.2.3 Asia Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
9.3 Asia Opioid Induced Side Effects Treatment Market Size by Application
9.3.1 Asia Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
9.3.2 Asia Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
9.3.3 Asia Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
9.4 Asia Opioid Induced Side Effects Treatment Market Size by Region
9.4.1 Asia Opioid Induced Side Effects Treatment Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Opioid Induced Side Effects Treatment Market Size by Region (2019-2024)
9.4.3 Asia Opioid Induced Side Effects Treatment Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Shionogi
11.1.1 Shionogi Company Details
11.1.2 Shionogi Business Overview
11.1.3 Shionogi Opioid Induced Side Effects Treatment Introduction
11.1.4 Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.1.5 Shionogi Recent Developments
11.2 Cubist Pharmaceuticals
11.2.1 Cubist Pharmaceuticals Company Details
11.2.2 Cubist Pharmaceuticals Business Overview
11.2.3 Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.2.4 Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.2.5 Cubist Pharmaceuticals Recent Developments
11.3 SLA Pharma
11.3.1 SLA Pharma Company Details
11.3.2 SLA Pharma Business Overview
11.3.3 SLA Pharma Opioid Induced Side Effects Treatment Introduction
11.3.4 SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.3.5 SLA Pharma Recent Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Opioid Induced Side Effects Treatment Introduction
11.4.4 AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.4.5 AstraZeneca Recent Developments
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Details
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid Induced Side Effects Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.5.5 AIKO Biotechnology Recent Developments
11.6 Progenics Pharmaceuticals
11.6.1 Progenics Pharmaceuticals Company Details
11.6.2 Progenics Pharmaceuticals Business Overview
11.6.3 Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Introduction
11.6.4 Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024)
11.6.5 Progenics Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Risperidone
Table 3. Key Players of Methylphenidate
Table 4. Key Players of Cetirizine
Table 5. Key Players of Other
Table 6. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Opioid Induced Side Effects Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Opioid Induced Side Effects Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Opioid Induced Side Effects Treatment Market Share by Region (2019-2024)
Table 10. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Opioid Induced Side Effects Treatment Market Share by Region (2025-2030)
Table 12. Opioid Induced Side Effects Treatment Market Trends
Table 13. Opioid Induced Side Effects Treatment Market Drivers
Table 14. Opioid Induced Side Effects Treatment Market Challenges
Table 15. Opioid Induced Side Effects Treatment Market Restraints
Table 16. Global Opioid Induced Side Effects Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Opioid Induced Side Effects Treatment Revenue Share by Players (2019-2024)
Table 18. Global Top Opioid Induced Side Effects Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2023)
Table 19. Global Opioid Induced Side Effects Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Opioid Induced Side Effects Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Opioid Induced Side Effects Treatment, Headquarters and Area Served
Table 22. Global Key Players of Opioid Induced Side Effects Treatment, Product and Application
Table 23. Global Key Players of Opioid Induced Side Effects Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2019-2024)
Table 31. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2025-2030)
Table 33. North America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Opioid Induced Side Effects Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Opioid Induced Side Effects Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Opioid Induced Side Effects Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Opioid Induced Side Effects Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 65. Shionogi Company Details
Table 66. Shionogi Business Overview
Table 67. Shionogi Opioid Induced Side Effects Treatment Product
Table 68. Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 69. Shionogi Recent Developments
Table 70. Cubist Pharmaceuticals Company Details
Table 71. Cubist Pharmaceuticals Business Overview
Table 72. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product
Table 73. Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 74. Cubist Pharmaceuticals Recent Developments
Table 75. SLA Pharma Company Details
Table 76. SLA Pharma Business Overview
Table 77. SLA Pharma Opioid Induced Side Effects Treatment Product
Table 78. SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 79. SLA Pharma Recent Developments
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Opioid Induced Side Effects Treatment Product
Table 83. AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 84. AstraZeneca Recent Developments
Table 85. AIKO Biotechnology Company Details
Table 86. AIKO Biotechnology Business Overview
Table 87. AIKO Biotechnology Opioid Induced Side Effects Treatment Product
Table 88. AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 89. AIKO Biotechnology Recent Developments
Table 90. Progenics Pharmaceuticals Company Details
Table 91. Progenics Pharmaceuticals Business Overview
Table 92. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product
Table 93. Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 94. Progenics Pharmaceuticals Recent Developments
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Opioid Induced Side Effects Treatment Market Share by Type: 2023 VS 2030
Figure 3. Risperidone Features
Figure 4. Methylphenidate Features
Figure 5. Cetirizine Features
Figure 6. Other Features
Figure 7. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Opioid Induced Side Effects Treatment Market Share by Application: 2023 VS 2030
Figure 9. Drug Overdose Treatment Case Studies
Figure 10. Pain Treatment Case Studies
Figure 11. Other Case Studies
Figure 12. Opioid Induced Side Effects Treatment Report Years Considered
Figure 13. Global Opioid Induced Side Effects Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Opioid Induced Side Effects Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Opioid Induced Side Effects Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Opioid Induced Side Effects Treatment Market Share by Players in 2023
Figure 17. Global Top Opioid Induced Side Effects Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Opioid Induced Side Effects Treatment Revenue in 2023
Figure 19. North America Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 21. North America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 22. North America Opioid Induced Side Effects Treatment Market Share by Country (2019-2030)
Figure 23. United States Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 27. Europe Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 28. Europe Opioid Induced Side Effects Treatment Market Share by Country (2019-2030)
Figure 29. Germany Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 37. China Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 38. Asia Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 40. Asia Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 41. Asia Opioid Induced Side Effects Treatment Market Share by Region (2019-2030)
Figure 42. Japan Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Country (2019-2030)
Figure 52. Brazil Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Shionogi Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 59. Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 60. SLA Pharma Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 61. AstraZeneca Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 62. AIKO Biotechnology Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 63. Progenics Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Table 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Risperidone
Table 3. Key Players of Methylphenidate
Table 4. Key Players of Cetirizine
Table 5. Key Players of Other
Table 6. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 7. Global Opioid Induced Side Effects Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Opioid Induced Side Effects Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Opioid Induced Side Effects Treatment Market Share by Region (2019-2024)
Table 10. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Opioid Induced Side Effects Treatment Market Share by Region (2025-2030)
Table 12. Opioid Induced Side Effects Treatment Market Trends
Table 13. Opioid Induced Side Effects Treatment Market Drivers
Table 14. Opioid Induced Side Effects Treatment Market Challenges
Table 15. Opioid Induced Side Effects Treatment Market Restraints
Table 16. Global Opioid Induced Side Effects Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Opioid Induced Side Effects Treatment Revenue Share by Players (2019-2024)
Table 18. Global Top Opioid Induced Side Effects Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2023)
Table 19. Global Opioid Induced Side Effects Treatment Industry Ranking 2022 VS 2023 VS 2024
Table 20. Global 5 Largest Players Market Share by Opioid Induced Side Effects Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 21. Global Key Players of Opioid Induced Side Effects Treatment, Headquarters and Area Served
Table 22. Global Key Players of Opioid Induced Side Effects Treatment, Product and Application
Table 23. Global Key Players of Opioid Induced Side Effects Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2019-2024)
Table 27. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Opioid Induced Side Effects Treatment Revenue Market Share by Type (2025-2030)
Table 29. Global Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2019-2024)
Table 31. Global Opioid Induced Side Effects Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Opioid Induced Side Effects Treatment Revenue Share by Application (2025-2030)
Table 33. North America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 34. North America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 35. North America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 36. North America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 37. North America Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. North America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. North America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Europe Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 41. Europe Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 42. Europe Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 43. Europe Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 44. Europe Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Europe Opioid Induced Side Effects Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Europe Opioid Induced Side Effects Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. China Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 48. China Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 49. China Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 50. China Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 51. Asia Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 52. Asia Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 53. Asia Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 54. Asia Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 55. Asia Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 56. Asia Opioid Induced Side Effects Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 57. Asia Opioid Induced Side Effects Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Type (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Application (2025-2030) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 63. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 65. Shionogi Company Details
Table 66. Shionogi Business Overview
Table 67. Shionogi Opioid Induced Side Effects Treatment Product
Table 68. Shionogi Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 69. Shionogi Recent Developments
Table 70. Cubist Pharmaceuticals Company Details
Table 71. Cubist Pharmaceuticals Business Overview
Table 72. Cubist Pharmaceuticals Opioid Induced Side Effects Treatment Product
Table 73. Cubist Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 74. Cubist Pharmaceuticals Recent Developments
Table 75. SLA Pharma Company Details
Table 76. SLA Pharma Business Overview
Table 77. SLA Pharma Opioid Induced Side Effects Treatment Product
Table 78. SLA Pharma Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 79. SLA Pharma Recent Developments
Table 80. AstraZeneca Company Details
Table 81. AstraZeneca Business Overview
Table 82. AstraZeneca Opioid Induced Side Effects Treatment Product
Table 83. AstraZeneca Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 84. AstraZeneca Recent Developments
Table 85. AIKO Biotechnology Company Details
Table 86. AIKO Biotechnology Business Overview
Table 87. AIKO Biotechnology Opioid Induced Side Effects Treatment Product
Table 88. AIKO Biotechnology Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 89. AIKO Biotechnology Recent Developments
Table 90. Progenics Pharmaceuticals Company Details
Table 91. Progenics Pharmaceuticals Business Overview
Table 92. Progenics Pharmaceuticals Opioid Induced Side Effects Treatment Product
Table 93. Progenics Pharmaceuticals Revenue in Opioid Induced Side Effects Treatment Business (2019-2024) & (US$ Million)
Table 94. Progenics Pharmaceuticals Recent Developments
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Opioid Induced Side Effects Treatment Market Share by Type: 2023 VS 2030
Figure 3. Risperidone Features
Figure 4. Methylphenidate Features
Figure 5. Cetirizine Features
Figure 6. Other Features
Figure 7. Global Opioid Induced Side Effects Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 8. Global Opioid Induced Side Effects Treatment Market Share by Application: 2023 VS 2030
Figure 9. Drug Overdose Treatment Case Studies
Figure 10. Pain Treatment Case Studies
Figure 11. Other Case Studies
Figure 12. Opioid Induced Side Effects Treatment Report Years Considered
Figure 13. Global Opioid Induced Side Effects Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Opioid Induced Side Effects Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Opioid Induced Side Effects Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global Opioid Induced Side Effects Treatment Market Share by Players in 2023
Figure 17. Global Top Opioid Induced Side Effects Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Side Effects Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Opioid Induced Side Effects Treatment Revenue in 2023
Figure 19. North America Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 21. North America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 22. North America Opioid Induced Side Effects Treatment Market Share by Country (2019-2030)
Figure 23. United States Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 26. Europe Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 27. Europe Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 28. Europe Opioid Induced Side Effects Treatment Market Share by Country (2019-2030)
Figure 29. Germany Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. China Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 36. China Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 37. China Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 38. Asia Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 39. Asia Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 40. Asia Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 41. Asia Opioid Induced Side Effects Treatment Market Share by Region (2019-2030)
Figure 42. Japan Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. South Korea Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. China Taiwan Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Southeast Asia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. India Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Australia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Size YoY (2019-2030) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Type (2019-2030)
Figure 50. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Application (2019-2030)
Figure 51. Middle East, Africa, and Latin America Opioid Induced Side Effects Treatment Market Share by Country (2019-2030)
Figure 52. Brazil Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Mexico Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Turkey Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Saudi Arabia Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. Israel Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. GCC Countries Opioid Induced Side Effects Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 58. Shionogi Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 59. Cubist Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 60. SLA Pharma Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 61. AstraZeneca Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 62. AIKO Biotechnology Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 63. Progenics Pharmaceuticals Revenue Growth Rate in Opioid Induced Side Effects Treatment Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232